EIP
LNAI

Ellis Investment Partners’s Lunai Bioworks LNAI Stock Holding History

Ellis Investment Partners’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1
Closed – – 618
2022
Q3 		$0 Hold
1
– – ﹤0.01% 822
2022
Q2 		$0 Hold
1
– – ﹤0.01% 821
2022
Q1 		$0 Hold
1
– – ﹤0.01% 843
2021
Q4 		$0 Hold
1
– – ﹤0.01% 825
2021
Q3 		$0 Hold
1
– – ﹤0.01% 801
2021
Q2 		$0 Sell
1
-5
-83% -$1.63K ﹤0.01% 786
2021
Q1 		$2K Hold
6
– – ﹤0.01% 731
2020
Q4 		$1K Hold
6
– – ﹤0.01% 719
2020
Q3 		$1K Hold
6
– – ﹤0.01% 701
2020
Q2 		$2K Hold
6
– – ﹤0.01% 673
2020
Q1 		$1K Sell
6
-13
-68% -$3.87K ﹤0.01% 689
2019
Q4 		$7K Hold
19
– – ﹤0.01% 566
2019
Q3 		$7K Buy
+19
New +$7.27K ﹤0.01% 578

Other funds holding LNAI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ellis Investment Partners's LNAI Position: Q4 2022 in Review

Ellis Investment Partners sold out of Lunai Bioworks (LNAI) in Q4 2022, closing a stake of 1 share.

Ellis Investment Partners first reported a position in LNAI in Q3 2019 and held it in 13 quarters. The position peaked at $7K in Q4 2019. 36 funds tracked by Wall St. Rank hold LNAI as of Q4 2022.

  • Ellis Investment Partners reported no remaining Lunai Bioworks position as of Q4 2022 after selling out during the quarter.
  • Ellis Investment Partners sold 1 Lunai Bioworks share in Q4 2022.
  • Ellis Investment Partners first reported a position in Lunai Bioworks in Q3 2019 and held it in 13 quarters.
  • Ellis Investment Partners's Lunai Bioworks position peaked at $7K in Q4 2019.
  • 36 funds tracked by Wall St. Rank held Lunai Bioworks as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.